VTE Training and Education for Healthcare Professionals
Stop the Clot®:
What Every Healthcare Professional Should Know
Course Overview: This self-paced, online course provides the most current foundational information on assessing, treating, and managing patients who have blood clots and clotting disorders.
Target Audience: Physicians, Pharmacists, Nurses, Nurse Practitioners, Physician Assistants, other healthcare professionals
- Basics of Blood Clots
- Thrombophilia and Blood Clots
- Anticoagulation Medications
- Post-Thrombotic Syndrome
- Pulmonary Hypertension
- Prevention of Blood Clots
At the conclusion of this curriculum, participants will be able to do the following:
- Explain three signs and symptoms of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Describe three factors that increase the risk of developing a blood clot in the form of a DVT and/or PE.
- Describe three management considerations for the use of anticoagulant medications.
- Explain three signs and symptoms of post-thrombotic syndrome that providers should include in patient education plans for blood clot survivors.
- Explain two facts about pulmonary hypertension and its relationship to PE.
- Describe three appropriate treatment/management options to prevent blood clot recurrence and secondary complications.
General knowledge of a discipline of study related to health care
This course has been approved for the following continuing education credits:
2.25 AMA PRA Category 1 Credits™
2.15 CPE (Contact hours in Pharmacy Education)
0.2 CEU (Continuing Education Units)
2 CNE (Continuing Nursing Education)
- CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Centers for Disease Control and Prevention and National Blood Clot Alliance. The Centers for Disease Control and Prevention is accredited by the ACCME® to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity. The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credits™.
- CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity provides 2 contact hours.
- CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.2 CEU’s for this program.
- CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 2.15 Contact Hours in pharmacy education.
Curriculum Development Work Group
- Mary Lou Damiano, BS, RN, M.Ed., Assistant Director, Arizona Hemophilia & Thrombosis Center, Arizona Cancer Center, and nursing consultant to the National Blood Clot Alliance (NBCA)
- Teresa Lang, PA-C, MPAS, MT(ASCP)SH, Physician Assistant, Vascular Medicine, Mayo Clinic, Rochester, Minnesota, and nursing consultant to NBCA
- Kathleen McCool, PharmD, BCPS, CACP, Supervisor; Clinical Pharmacy Anticoagulation and Anemia Services, Kaiser Permanente, Denver, Colorado, and pharmacy consultant to NBCA
- Darren Triller, Pharm D., President & CEO, WellScriptEd Consulting, Inc., Delmar, New York, and pharmacy consultant to NBCA
- Elizabeth (Liz) Varga MS, LGC, Genetic and Genomic Services Coordinator; Co-Director of Personalized Medicine, Nationwide Children’s Hospital, Columbus, Ohio, and consultant to NBCA
- Diane Wirth, MS ANP-BC CACP, Manager, Heart Failure and VTE Clinic, Grady Memorial Hospital, Atlanta, Georgia, and nursing consultant to NBCA
National Blood Clot Alliance, Medical and Scientific Advisory Board, Medical Reviewers
- Jack Ansell, MD, Professor of Medicine, Hofstra Northwell School of Medicine, Hempstead, New York
- Alok Khorana, MD, Professor of Medicine, Staff, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio
DISCLOSURE: In compliance with continuing education requirements, all planners, presenters, and their spouses/partners must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigation use.
CDC and NBCA planners, content experts, and their spouses and partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of the following:
- Dr. Jack Ansell, and he wishes to disclose that he receives stock options, is a consultant and a Scientific Advisory Board member to Perosphere Inc. He also is a consultant to Alere Home Monitoring.
- Dr. Alok Khorana, and he wishes to disclose he receives honoraria as a consultant to Janssen, Bayer, Pfizer, Sanofi, Halozyme, AngioDynamics, Pharmacyte, Pharmacyclics, and Incyte.
- Elizabeth Varga, and she wishes to disclose that she had a short-term (4 month) consulting contract with Roche related to thrombophilia (FVL/factor II testing), advising on marketing and educational materials.
Planning committee discussed conflict of interest with Dr. Khorana to ensure there is no bias.
Planning committee reviewed content provided by Dr. Ansell and Ms. Varga to ensure there is no bias.
To access this online curriculum, please enable cookies in your browser.
If you have already registered and are returning to continue your course, please click hereexternal icon.
Please address general questions or comments about the curriculum to firstname.lastname@example.org.
If you have questions or comments about the evaluation portion of the curriculum, or the acquisition of continuing education credit, please contact: CDC/ATSDR Training and Continuing Education Online, 1-800-41TRAIN, or email at email@example.com.